RICHMOND, Va., April 12 /PRNewswire/ — Selenium levels may predict the
risk of a man’s prostate cancer, and now a simple, reliable selenium
test is available.

The first selenium test that predicts prostate cancer risk, SeleniumHealth(TM), is now available exclusively from Bostwick Laboratories, Inc., an international diagnostic pathology laboratory. A man simply trims one or more toenails and submits the clippings for selenium content. SeleniumHealth(TM) is provided by Bostwick Laboratories, Inc. under license from the Gerald P. Murphy Cancer Foundation.

Press release at: Bostwick Labs